Effect of Omega-3 Index on Cellular Metabolism and Quality of Life

SCF Pharma

Status and phase: Completed; Phase 4

Conditions: Healthy

Treatments: Dietary Supplement: MAG-EPA

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT03159507

IO3-01

Details and patient eligibility

About

Determine whether personal optimization of the Omega-3 index improves cellular metabolism and quality of life (according to the SF-36 form).

Enrollment: 16 patients

Sex: All

Ages: 19+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Participant aged 19 or over
• Available for the entire duration of the study and willing to participate on the basis of the information provided in the FIU duly read and signed.

Exclusion criteria

• Allergy known to fish
• Pregnant women who breast-feed or test positive for pregnancy

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

16 participants in 1 patient group

MAG-EPA

Experimental group

Description:

MAG-EPA softgel (500mg), daily dose between 1g and 3.5g

Treatment:

Dietary Supplement: MAG-EPA